Arintra, a frontrunner in GenAI-powered autonomous medical coding, has announced a $21 million Series A funding round to transform healthcare revenue assurance. Peak XV Partners led the investment, joined by Endeavor Health Ventures, Y Combinator, Counterpart Ventures, Spider Capital, Ten13, and other strategic investors. This capital will fuel Arintra’s expansion across health systems and physician groups nationwide, accelerate product development, and establish a new Bay Area headquarters to meet growing demand. Healthcare organizations are facing unprecedented financial pressures with shrinking margins, coder shortages, and increasingly complex payer requirements. Proactive automation solutions are crucial for providers to stay ahead of evolving insurance reimbursement policies. While traditional coding solutions focus on accurate chart coding, Arintra delivers comprehensive Revenue Assurance. This proactive, outcomes-driven approach ensures accurate and efficient reimbursement, streamlining the revenue cycle, reducing costs, and delivering tangible ROI.
Preeti Bhargava, Co-founder and CTO of Arintra, stated, “Our platform integrates autonomous medical coding, clinical documentation improvement, and denial prevention.” By facilitating accurate documentation, coding, and charge support, Arintra enables full, compliant reimbursement with reduced costs, delays, and manual effort. Arintra has already processed over a billion dollars in healthcare charges, recovering millions in missed revenue while minimizing manual work and accelerating cash flow. Mercyhealth experienced a 5.1% revenue increase, a 43% denial reduction, a 50% work queue aging reduction, and a 32% coding cost decrease. Reid Health improved accounts receivable and coding accuracy using Arintra. Muhammad Siddiqui, CIO at Reid Health, noted, “Arintra integrates deeply with Epic, transforming our coding process without disrupting workflows. We’ve moved from billing delays and high denials to faster A/R and fully automated charge capture, delivering rapid ROI.” The concept for Arintra arose from a personal billing issue experienced by co-founder Preeti Bhargava. This highlighted systemic issues in care documentation and reimbursement, revealing vulnerabilities for both patients and healthcare organizations due to technical coding errors. This motivated Preeti and Nitesh to analyze the problem with a modern technical perspective, positioning medical coding as a strategic tool for improving healthcare’s financial health.
Nitesh Shroff, Co-founder and CEO of Arintra, explained, “Healthcare reimbursement is fundamentally flawed. Payers are shifting burdens onto providers, and autonomous coding hasn’t kept pace. Arintra helps providers secure compliant revenue at scale while reducing the burden on frontline teams.” Mohit Bhatnagar, MD, Peak XV, commented, “Arintra’s system addresses translating clinical documentation into accurate insurance codes, helping providers recover millions in lost revenue. It exemplifies vertical AI excellence with real enterprise adoption, clear ROI, and an ambitious roadmap.”
Arintra’s GenAI platform utilizes large language models and clinical knowledge graphs to interpret patient charts within context, applying specialty-specific coding guidelines. The platform integrates with EHRs like Epic and Athena, operating seamlessly within existing workflows. Arintra’s codes are fully explainable and auditable, building trust in critical processes. Arintra continues to expand its capabilities to help healthcare organizations achieve sustainable financial outcomes, solidifying its position as a trusted partner for revenue assurance. About Arintra: Arintra delivers the leading GenAI-native autonomous coding platform, ensuring accurate and efficient reimbursement for healthcare providers. By combining AI with clinical expertise, Arintra automates coding with high accuracy, directly within the EHR, unlocking revenue and reducing A/R days and denials.
Also Read: Inside BharatPe’s Remarkable FY25 Comeback and IPO-Ready Strategy
